Muneeba Khan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Muneeba Khan has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Erum Shahzadi Malik
Dow University of Health Sciences, Karachi, Pakistan
5 shared publications - Muhammad Hashim
Dow University of Health Sciences, Karachi, Pakistan
3 shared publications - Muhammad Tariq Farman
Dow University of Health Sciences, Karachi, Pakistan
3 shared publications - Afzal Qasim
Dow University of Health Sciences, Karachi, Pakistan
2 shared publications - Riffat Tanveer2 shared publications
- Ariful Haque
Department of Orthopedic Surgery, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, China
1 shared publication
Latest Publications
- Open Access
- 27 July 2026
- Published by Wiley in Clinical Cardiology
- Vol. 49 (8)
Mortality Trend in Patients With Heart Failure and Psychoactive Substance Abuse in the United States—Pre‐ and Post‐COVID‐19 Pandemic Perspective (1999−2023)
Background: This study evaluates national trends in heart failure (HF) and psychoactive substance abuse‐related mortality among adults aged 25 years and older in the United States (US) from 1999 to 2023, stratified by sex, age, race/ethnicity, geographic regions, and the COVID‐19 pandemic period. Methods: Data from 1999 to 2023 were extracted from the CDC WONDER database. Age‐adjusted mortality rates (AAMR) and annual percentage changes (APC) were calculated using Joinpoint regression. ICD‐10 codes I50, I50.1, I50.9 (Heart Failure), and F10‐19 (Psychoactive Substance Use) were used to identify the conditions. Results: A total of 771 739 deaths were recorded from 1999 to 2023 among individuals aged 25 and older. Most deaths occurred in medical facilities (39.24%), followed by decedents' homes (34.14%), long‐term care facilities (16.30%), hospice (6.65%), and other settings (3.67%). The AAMR increased markedly from 1.68 in 1999 to 20.7 in 2023 (AAPC of 12.09, 95% confidence interval [CI]: 10.97−14.26). A substantial increase was observed from 1999 to 2005 (APC: 38.5%, 95% CI: 29.1–55.8), followed by a slower increase until 2020 (APC: 5.68%, 95% CI: 5.02–14.8). Men showed consistently higher AAMRs than females (18.8 vs. 8.65). By age group, mortality was highest among individuals aged 65 years and older. Conclusion: Using CDC WONDER data (1999–2023), we found a sharp rise in HF mortality linked to psychoactive substance abuse, from 1.68 to 20.7 per 100 000. Mortality burden was highest among males, older adults, non‐Hispanic White individuals, and rural populations, highlighting widening demographic and geographic disparities.
- 27 July 2026
- Published by Wiley in Clinical Cardiology
- Vol. 49 (8)
Open AccessMortality Trend in Patients With Heart Failure and Psychoactive Substance Abuse in the United States—Pre‐ and Post‐COVID‐19 Pandemic Perspective (1999−2023)
Background: This study evaluates national trends in heart failure (HF) and psychoactive substance abuse‐related mortality among adults aged 25 years and older in the United States (US) from 1999 to 2023, stratified by sex, age, race/ethnicity, geographic regions, and the COVID‐19 pandemic period. Methods: Data from 1999 to 2023 were extracted from the CDC WONDER database. Age‐adjusted mortality rates (AAMR) and annual percentage changes (APC) were calculated using Joinpoint regression. ICD‐10 codes I50, I50.1, I50.9 (Heart Failure), and F10‐19 (Psychoactive Substance Use) were used to identify the conditions. Results: A total of 771 739 deaths were recorded from 1999 to 2023 among individuals aged 25 and older. Most deaths occurred in medical facilities (39.24%), followed by decedents' homes (34.14%), long‐term care facilities (16.30%), hospice (6.65%), and other settings (3.67%). The AAMR increased markedly from 1.68 in 1999 to 20.7 in 2023 (AAPC of 12.09, 95% confidence interval [CI]: 10.97−14.26). A substantial increase was observed from 1999 to 2005 (APC: 38.5%, 95% CI: 29.1–55.8), followed by a slower increase until 2020 (APC: 5.68%, 95% CI: 5.02–14.8). Men showed consistently higher AAMRs than females (18.8 vs. 8.65). By age group, mortality was highest among individuals aged 65 years and older. Conclusion: Using CDC WONDER data (1999–2023), we found a sharp rise in HF mortality linked to psychoactive substance abuse, from 1.68 to 20.7 per 100 000. Mortality burden was highest among males, older adults, non‐Hispanic White individuals, and rural populations, highlighting widening demographic and geographic disparities.
- Open Access
- 30 June 2026
- Published by Pakistan Cardiac Society in Pakistan Heart Journal
- Vol. 59 (3) , 707-716
Comparison of Atherogenic Coefficient and Castelli Risk Indices in Diabetic and Non-Diabetic Patients Presenting with Acute Coronary Syndrome
Objectives: Lipid-derived indices such as the Atherogenic Coefficient (AC) and Castelli Risk Indices (CRI-I and CRI-II) provide composite measures of atherogenic and protective lipoproteins and may offer improved risk stratification. Aim of this study was to compare AC, CRI-I, and CRI-II between diabetic and non-diabetic patients presenting with ACS and to evaluate their association with demographic and clinical characteristics. Methodology: This cross-sectional study enrolled 103 patients admitted with ACS at a tertiary care center. Demographic data, clinical characteristics, and fasting lipid profiles were collected. AC, CRI-I, and CRI-II were calculated using standard formulas. Group comparisons were performed using appropriate parametric and non-parametric tests. Multivariable linear regression was used to identify independent predictors of atherogenic indices. Results: The mean age of participants was 59.4 ± 12.7 years, with 47.6% having diabetes mellitus. AC and CRI-I did not differ significantly between diabetic and non-diabetic participants, whereas CRI-II was significantly higher among non-diabetics (p = 0.024). Smoking was consistently associated with higher AC, CRI-I, and CRI-II and emerged as the strongest independent predictor across all multivariable models (p < 0.05). Other traditional cardiovascular risk factors, including age, sex, diabetes mellitus, hypertension, anemia, and physical activity, were not independently associated with atherogenic indices after adjustment. Conclusion: Among patients presenting with ACS, smoking is the most consistent determinant of elevated atherogenic indices, whereas diabetes mellitus and other traditional risk factors do not independently predict these indices after multivariable adjustment. Lipid-derived indices, particularly CRI-II, may provide complementary information for residual cardiovascular risk assessment in high-risk ACS populations, especially in resource-limited settings.
- 30 June 2026
- Published by Pakistan Cardiac Society in Pakistan Heart Journal
- Vol. 59 (3) , 707-716
Open AccessComparison of Atherogenic Coefficient and Castelli Risk Indices in Diabetic and Non-Diabetic Patients Presenting with Acute Coronary Syndrome
Objectives: Lipid-derived indices such as the Atherogenic Coefficient (AC) and Castelli Risk Indices (CRI-I and CRI-II) provide composite measures of atherogenic and protective lipoproteins and may offer improved risk stratification. Aim of this study was to compare AC, CRI-I, and CRI-II between diabetic and non-diabetic patients presenting with ACS and to evaluate their association with demographic and clinical characteristics. Methodology: This cross-sectional study enrolled 103 patients admitted with ACS at a tertiary care center. Demographic data, clinical characteristics, and fasting lipid profiles were collected. AC, CRI-I, and CRI-II were calculated using standard formulas. Group comparisons were performed using appropriate parametric and non-parametric tests. Multivariable linear regression was used to identify independent predictors of atherogenic indices. Results: The mean age of participants was 59.4 ± 12.7 years, with 47.6% having diabetes mellitus. AC and CRI-I did not differ significantly between diabetic and non-diabetic participants, whereas CRI-II was significantly higher among non-diabetics (p = 0.024). Smoking was consistently associated with higher AC, CRI-I, and CRI-II and emerged as the strongest independent predictor across all multivariable models (p < 0.05). Other traditional cardiovascular risk factors, including age, sex, diabetes mellitus, hypertension, anemia, and physical activity, were not independently associated with atherogenic indices after adjustment. Conclusion: Among patients presenting with ACS, smoking is the most consistent determinant of elevated atherogenic indices, whereas diabetes mellitus and other traditional risk factors do not independently predict these indices after multivariable adjustment. Lipid-derived indices, particularly CRI-II, may provide complementary information for residual cardiovascular risk assessment in high-risk ACS populations, especially in resource-limited settings.
- Open Access
- 30 June 2026
- Published by Pakistan Cardiac Society in Pakistan Heart Journal
- Vol. 59 (3) , 545-552
Frequency and Clinical Correlates of Elevated Atherogenic Index of Plasma in Patients with Acute Myocardial Infarction: A Cross-Sectional Study from a Tertiary Care Center
Objectives: The Atherogenic Index of Plasma (AIP), defined as the logarithmic ratio of triglycerides to high-density lipoprotein cholesterol, is an emerging lipid-derived marker that reflects the balance between atherogenic and protective lipoproteins. Aim of this study was to determine the frequency of elevated Atherogenic Index of Plasma and examine its association with demographic and clinical characteristics among patients presenting with acute myocardial infarction (AMI). Methodology: This cross-sectional study included 103 patients diagnosed with AMI at a tertiary care hospital. AIP was calculated using fasting lipid parameters, with triglyceride and HDL-C values converted to mmol/L prior to applying the logarithmic formula. AIP values were categorized into low (0.24) groups. Demographic and clinical variables were recorded, and exploratory multivariable logistic regression analysis was performed to identify independent predictors of elevated AIP. Results: High-risk AIP (>0.24) was observed in 55.4% of patients, while 13.6% and 32.0% were classified as intermediate and low risk, respectively. Age above 50 years was significantly associated with elevated AIP (p = 0.018) and remained the only independent predictor in multivariable analysis (adjusted OR 2.83, 95% CI 1.25–6.63, p = 0.014). Lipid parameters showed strong correlations with AIP, with triglycerides positively (ρ = 0.887, p < 0.001) and HDL-C negatively (ρ = −0.622, p < 0.001) associated. Other clinical variables, including gender, diabetes, hypertension, smoking, anemia, and physical activity, were not significantly associated after adjustment. Conclusion: Elevated AIP is highly prevalent among patients presenting with AMI and is primarily driven by underlying lipid abnormalities. While age appears to be an independent predictor, the cross-sectional design limits causal inference. Further large-scale prospective studies are required to evaluate the prognostic significance of AIP in cardiovascular risk stratification.
- 30 June 2026
- Published by Pakistan Cardiac Society in Pakistan Heart Journal
- Vol. 59 (3) , 545-552
Open AccessFrequency and Clinical Correlates of Elevated Atherogenic Index of Plasma in Patients with Acute Myocardial Infarction: A Cross-Sectional Study from a Tertiary Care Center
Objectives: The Atherogenic Index of Plasma (AIP), defined as the logarithmic ratio of triglycerides to high-density lipoprotein cholesterol, is an emerging lipid-derived marker that reflects the balance between atherogenic and protective lipoproteins. Aim of this study was to determine the frequency of elevated Atherogenic Index of Plasma and examine its association with demographic and clinical characteristics among patients presenting with acute myocardial infarction (AMI). Methodology: This cross-sectional study included 103 patients diagnosed with AMI at a tertiary care hospital. AIP was calculated using fasting lipid parameters, with triglyceride and HDL-C values converted to mmol/L prior to applying the logarithmic formula. AIP values were categorized into low (0.24) groups. Demographic and clinical variables were recorded, and exploratory multivariable logistic regression analysis was performed to identify independent predictors of elevated AIP. Results: High-risk AIP (>0.24) was observed in 55.4% of patients, while 13.6% and 32.0% were classified as intermediate and low risk, respectively. Age above 50 years was significantly associated with elevated AIP (p = 0.018) and remained the only independent predictor in multivariable analysis (adjusted OR 2.83, 95% CI 1.25–6.63, p = 0.014). Lipid parameters showed strong correlations with AIP, with triglycerides positively (ρ = 0.887, p < 0.001) and HDL-C negatively (ρ = −0.622, p < 0.001) associated. Other clinical variables, including gender, diabetes, hypertension, smoking, anemia, and physical activity, were not significantly associated after adjustment. Conclusion: Elevated AIP is highly prevalent among patients presenting with AMI and is primarily driven by underlying lipid abnormalities. While age appears to be an independent predictor, the cross-sectional design limits causal inference. Further large-scale prospective studies are required to evaluate the prognostic significance of AIP in cardiovascular risk stratification.
- Open Access
- 1 May 2026
- Published by Pakistan Cardiac Society in Pakistan Heart Journal
- Vol. 59 (2) , 470-476
Angiographic Severity of Coronary Artery Disease in Diabetic vs. Non-Diabetic Patients Presenting With NSTEMI: A Comparative Cross-Sectional Study
Objectives: Diabetes mellitus (DM) is a major cardiovascular risk factor associated with diffuse and aggressive atherosclerosis, yet contemporary data comparing angiographic severity between diabetic and non-diabetic patients with Non-ST Elevation Myocardial Infarction (NSTEMI) remain limited in South Asia. Understanding these differences is critical for improving risk stratification and guiding timely intervention. Methodology: This comparative cross-sectional study included 200 NSTEMI patients—100 diabetics and 100 non-diabetics—enrolled after screening 298 consecutive cases. Clinical, biochemical, and angiographic characteristics were recorded. Coronary artery disease (CAD) severity was quantified using the Gensini score. Regression analyses (linear and logistic) were performed to identify independent predictors of severe CAD, with model adjustments made for metabolic and cardiovascular risk factors. Results: Diabetic patients demonstrated a significantly more adverse metabolic profile, including higher HbA1c, increased creatinine, and greater prevalence of dyslipidemia (all p < 0.001). Angiographically, diabetics exhibited a higher mean Gensini score (83.88 ± 31.09) than non-diabetics (59.02 ± 34.37; p < 0.001), and a markedly higher frequency of triple-vessel disease (43% vs. 21%; p = 0.001). In multivariate analyses, diabetes mellitus (OR 3.12; 95% CI: 1.68–5.80; p < 0.001) and dyslipidemia (OR 2.24; 95% CI: 1.21–4.16; p = 0.010) remained strong independent predictors of severe CAD. Conclusion: Diabetes mellitus is strongly associated with more widespread and severe coronary artery involvement in NSTEMI patients. These findings highlight the need for earlier risk identification, aggressive metabolic control, and timely invasive evaluation among diabetic individuals presenting with ACS.
- 1 May 2026
- Published by Pakistan Cardiac Society in Pakistan Heart Journal
- Vol. 59 (2) , 470-476
Open AccessAngiographic Severity of Coronary Artery Disease in Diabetic vs. Non-Diabetic Patients Presenting With NSTEMI: A Comparative Cross-Sectional Study
Objectives: Diabetes mellitus (DM) is a major cardiovascular risk factor associated with diffuse and aggressive atherosclerosis, yet contemporary data comparing angiographic severity between diabetic and non-diabetic patients with Non-ST Elevation Myocardial Infarction (NSTEMI) remain limited in South Asia. Understanding these differences is critical for improving risk stratification and guiding timely intervention. Methodology: This comparative cross-sectional study included 200 NSTEMI patients—100 diabetics and 100 non-diabetics—enrolled after screening 298 consecutive cases. Clinical, biochemical, and angiographic characteristics were recorded. Coronary artery disease (CAD) severity was quantified using the Gensini score. Regression analyses (linear and logistic) were performed to identify independent predictors of severe CAD, with model adjustments made for metabolic and cardiovascular risk factors. Results: Diabetic patients demonstrated a significantly more adverse metabolic profile, including higher HbA1c, increased creatinine, and greater prevalence of dyslipidemia (all p < 0.001). Angiographically, diabetics exhibited a higher mean Gensini score (83.88 ± 31.09) than non-diabetics (59.02 ± 34.37; p < 0.001), and a markedly higher frequency of triple-vessel disease (43% vs. 21%; p = 0.001). In multivariate analyses, diabetes mellitus (OR 3.12; 95% CI: 1.68–5.80; p < 0.001) and dyslipidemia (OR 2.24; 95% CI: 1.21–4.16; p = 0.010) remained strong independent predictors of severe CAD. Conclusion: Diabetes mellitus is strongly associated with more widespread and severe coronary artery involvement in NSTEMI patients. These findings highlight the need for earlier risk identification, aggressive metabolic control, and timely invasive evaluation among diabetic individuals presenting with ACS.
- Open Access
- 30 December 2025
- Published by Pakistan Cardiac Society in Pakistan Heart Journal
- Vol. 58 (s3) , 214-220
Incidence and Determinants of Early Radial Artery Occlusion Following Transradial Coronary Angiography and Intervention: A Prospective Observational Study
Objectives: To determine the 24-hour incidence of Doppler-confirmed radial artery occlusion and identify clinical and procedural predictors of RAO in patients undergoing transradial coronary procedures. Methodology: This prospective observational study enrolled 196 adult patients undergoing TRA coronary angiography or PCI at a tertiary cardiac center from March to September 2024. Clinical, laboratory, and procedural data were documented. RAO was assessed 24 hours post-procedure using color Doppler ultrasonography. Univariate and multivariable logistic regression analyses were performed to identify independent predictors of RAO. Results: Among 196 patients (mean age 59.6 ± 11.7 years; 65.3% male), the 24-hour incidence of RAO was 11.2% (n = 22). Patients with RAO had significantly higher HbA1c levels (p = 0.002), higher rates of multiple puncture attempts (p < 0.001), complex PCI (p < 0.001), and higher-grade hematomas (p < 0.001). On multivariable analysis, prolonged hemostasis duration emerged as the only independent predictor of RAO (adjusted OR 1.13, 95% CI 1.06–1.20; p < 0.001). Conclusion: Prolonged hemostasis duration is a strong independent determinant of early RAO following transradial coronary procedures. Optimization of patent hemostasis techniques and minimizing compression time may significantly reduce RAO and preserve long-term radial artery patency.
- 30 December 2025
- Published by Pakistan Cardiac Society in Pakistan Heart Journal
- Vol. 58 (s3) , 214-220
Open AccessIncidence and Determinants of Early Radial Artery Occlusion Following Transradial Coronary Angiography and Intervention: A Prospective Observational Study
Objectives: To determine the 24-hour incidence of Doppler-confirmed radial artery occlusion and identify clinical and procedural predictors of RAO in patients undergoing transradial coronary procedures. Methodology: This prospective observational study enrolled 196 adult patients undergoing TRA coronary angiography or PCI at a tertiary cardiac center from March to September 2024. Clinical, laboratory, and procedural data were documented. RAO was assessed 24 hours post-procedure using color Doppler ultrasonography. Univariate and multivariable logistic regression analyses were performed to identify independent predictors of RAO. Results: Among 196 patients (mean age 59.6 ± 11.7 years; 65.3% male), the 24-hour incidence of RAO was 11.2% (n = 22). Patients with RAO had significantly higher HbA1c levels (p = 0.002), higher rates of multiple puncture attempts (p < 0.001), complex PCI (p < 0.001), and higher-grade hematomas (p < 0.001). On multivariable analysis, prolonged hemostasis duration emerged as the only independent predictor of RAO (adjusted OR 1.13, 95% CI 1.06–1.20; p < 0.001). Conclusion: Prolonged hemostasis duration is a strong independent determinant of early RAO following transradial coronary procedures. Optimization of patent hemostasis techniques and minimizing compression time may significantly reduce RAO and preserve long-term radial artery patency.